Business
US patent to 2034 granted for Neurens NNZ-2591 in autism
US patent to 2034 granted for Neurens NNZ-2591 in autism
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]